These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38953155)

  • 1. Reply to the letter regarding the article 'The prevalence, predictors, and outcomes of left ventricular thrombus in HFrEF'.
    Zhou XD; Chen QF; Shan P
    ESC Heart Fail; 2024 Oct; 11(5):3455-3456. PubMed ID: 38953155
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevalence, predictors, and outcomes of spontaneous echocardiographic contrast or left ventricular thrombus in patients with HFrEF.
    Zhou X; Shi R; Wu G; Zhu Q; Zhou C; Wang L; Xue C; Jiang Y; Cai X; Huang W; Shan P
    ESC Heart Fail; 2021 Apr; 8(2):1284-1294. PubMed ID: 33496071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
    Zhang L; Liebelt JJ; Madan N; Shan J; Taub CC
    Am J Cardiol; 2017 Jun; 119(11):1815-1820. PubMed ID: 28450040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
    Si J; Ding Z; Hu Y; Zhang X; Zhang Y; Cao H; Liu Y
    J Cardiol; 2024 Apr; 83(4):250-257. PubMed ID: 37802201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penalized Model-Based Unsupervised Phenomapping Unravels Distinctive HFrEF Phenotypes With Improved Outcomes Discrimination From Sacubitril/Valsartan Treatment Independent of MAGGIC Score.
    Sung KT; Chang HY; Hsu NW; Huang WH; Lin YH; Yun CH; Hsiao CC; Hsu CY; Tsai SY; Chen YJ; Tsai CT; Su CH; Hung TC; Hou CJ; Yeh HI; Hung CL
    J Am Heart Assoc; 2023 Sep; 12(18):e028860. PubMed ID: 37681571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Ventricular Thrombus Formation in a Young Female With a Severely Reduced Left Ventricular Ejection Fraction and a Recent Non-ST Segment Elevation-Acute Coronary Syndrome.
    Patel KR; Kassir M; Patel M; Eichorn W
    Cureus; 2021 Sep; 13(9):e17804. PubMed ID: 34660014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction.
    Zhang X; Sun Y; Zhang Y; Chen F; Dai M; Si J; Yang J; Li X; Li J; Xia Y; Tse G; Liu Y
    ESC Heart Fail; 2021 Dec; 8(6):5383-5391. PubMed ID: 34569712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pueraria on left ventricular remodelling in HFrEF: A systematic review and meta-analysis.
    Shi L; Huang L; Yin E; Deng J; Du X
    PLoS One; 2023; 18(12):e0295344. PubMed ID: 38048301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closed loop stimulation in patients with chronic heart failure and severe chronotropic incompetence: Responders versus non-responders.
    Proff J; Merkely B; Papp R; Lenz C; Nordbeck P; Butter C; Meyhoefer J; Doering M; MacCarter D; Ingel K; Wolfarth B; Thouet T; Landmesser U; Roser M
    Int J Cardiol; 2023 Jan; 370():222-228. PubMed ID: 36243181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors of cardiac thrombus prior to ventricular tachycardia catheter ablation in structural heart disease.
    Bonnin T; Roumegou P; Sridi S; Mahida S; Bustin A; Duchateau J; Tixier R; Derval N; Pambrun T; Chniti G; Takagi T; Kamakura T; Krisai P; Andre C; Chauvel R; Hocini M; Haissaguerre M; Jais P; Cochet H; Sacher F
    Europace; 2023 Feb; 25(2):487-495. PubMed ID: 36355748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Ventricular Thrombus After Acute Decompensated Heart Failure in the Setting of Ischemic Cardiomyopathy.
    Satish M; Vukka N; Apala D; Mahfood Haddad T; Gupta J
    Cureus; 2019 Apr; 11(4):e4537. PubMed ID: 31263645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ivabradine in heart failure: a meta-analysis of heart failure patients with reduced versus preserved ejection fraction.
    Tóth N; Soós A; Váradi A; Hegyi P; Tinusz B; Vágvölgyi A; Orosz A; Solymár M; Polyák A; Varró A; Farkas AS; Nagy N
    Can J Physiol Pharmacol; 2021 Nov; 99(11):1159-1174. PubMed ID: 34636643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and Prognostic Value of Worsening Renal Function During Admission in HFpEF Versus HFrEF: Data From the KorAHF (Korean Acute Heart Failure) Registry.
    Kang J; Park JJ; Cho YJ; Oh IY; Park HA; Lee SE; Kim MS; Cho HJ; Lee HY; Choi JO; Hwang KK; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter.
    Wybraniec MT; Mizia-Szubryt M; Cichoń M; Wrona-Kolasa K; Kapłon-Cieślicka A; Gawałko M; Budnik M; Uziębło-Życzkowska B; Krzesiński P; Starzyk K; Gorczyca-Głowacka I; Daniłowicz-Szymanowicz L; Kaufmann D; Wójcik M; Błaszczyk R; Hiczkiewicz J; Łojewska K; Kosmalska K; Fijałkowski M; Szymańska A; Wiktorska A; Haberka M; Kucio M; Michalski B; Kupczyńska K; Tomaszuk-Kazberuk A; Wilk-Śledziewska K; Wachnicka-Truty R; Koziński M; Burchardt P; Mizia-Stec K
    ESC Heart Fail; 2022 Dec; 9(6):4064-4076. PubMed ID: 36039813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Ventricular Thrombi: Insights from Cardiac Magnetic Resonance Imaging.
    Chaosuwannakit N; Makarawate P
    Tomography; 2021 May; 7(2):180-188. PubMed ID: 34065998
    [No Abstract]   [Full Text] [Related]  

  • 17. Obesity paradox in pulmonary hypertension due to left ventricular systolic dysfunction.
    Wang L; Zhao LP; Chen Y; Chang X; Jin F; Liu X
    Herz; 2021 Dec; 46(6):575-580. PubMed ID: 33544153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of diabetes mellitus on left ventricular function and remodeling in hypertensive patients with heart failure with reduced ejection fraction: assessment with 3.0 T MRI feature tracking.
    Zhang G; Shi K; Yan WF; Li XM; Li Y; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2022 May; 21(1):69. PubMed ID: 35524215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sacubitril/valsartan on clinical symptoms, echocardiographic parameters, and outcomes in HFrEF and HFmrEF patients with coronary heart disease and chronic kidney disease.
    Raphael DM; Liu Z; Jin Z; Cui X; Han D; He W; Shangguan J; Shen D
    Curr Med Res Opin; 2021 Jul; 37(7):1071-1078. PubMed ID: 33764230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
    Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.